Dietary saturated fatty acid and polyunsaturated fatty acid oppositely affect hepatic NOD-like receptor protein 3 inflammasome through regulating nuclear factor-kappa B activation

World Journal of Gastroenterology

Volumn 22, Issue 8, 2016, Pages 2533-2544

  Sui, Yong Heng ^a   Luo, Wen Jing ^a   Xu, Qin Yu ^a   Hua, Jing ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

NODlike receptor protein 3 inflammasome; Non alcoholic fatty liver disease; Nuclear factor kappa B; Polyunsaturated fatty acids; Saturated fatty acids

Indexed keywords

CRYOPYRIN; DOCOSAHEXAENOIC ACID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INFLAMMASOME; INTERLEUKIN 1BETA; INTERLEUKIN 1BETA CONVERTING ENZYME; MESSENGER RNA; PALMITIC ACID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; SYNAPTOTAGMIN I; TUMOR NECROSIS FACTOR ALPHA; IL1B PROTEIN, MOUSE; LIPOPOLYSACCHARIDE; NLRP3 PROTEIN, MOUSE; RELA PROTEIN, MOUSE; TRANSCRIPTION FACTOR RELA;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DISEASE ASSOCIATION; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; LIPID DIET; LIPID STORAGE; LIVER CELL; MALE; MOUSE; NONALCOHOLIC FATTY LIVER; NONHUMAN; PROTEIN CLEAVAGE; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN PHOSPHORYLATION; UPREGULATION; ANIMAL; C57BL MOUSE; CELL CULTURE; DISEASE MODEL; DRUG EFFECTS; GENETICS; LIVER; METABOLISM; NON-ALCOHOLIC FATTY LIVER DISEASE; PHOSPHORYLATION; PRIMARY CELL CULTURE; SIGNAL TRANSDUCTION;

ANIMALS; CASPASE 1; CELLS, CULTURED; DIET, HIGH-FAT; DISEASE MODELS, ANIMAL; DOCOSAHEXAENOIC ACIDS; HEPATOCYTES; INFLAMMASOMES; INTERLEUKIN-1BETA; LIPOPOLYSACCHARIDES; LIVER; MALE; MICE, INBRED C57BL; NLR FAMILY, PYRIN DOMAIN-CONTAINING 3 PROTEIN; NON-ALCOHOLIC FATTY LIVER DISEASE; PALMITIC ACID; PHOSPHORYLATION; PPAR GAMMA; PRIMARY CELL CULTURE; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTOR RELA;

EID: 84959880427     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v22.i8.2533     Document Type: Article

References (33)

1. Hotamisligil GS. Inflammation and metabolic disorders. Nature 2006; 444: 860-867 [PMID: 17167474 DOI: 10.1038/nature05485]
2. Maher JJ, Leon P, Ryan JC. Beyond insulin resistance: Innate immunity in nonalcoholic steatohepatitis. Hepatology 2008; 48: 670-678 [PMID: 18666225 DOI: 10.1002/hep.22399]
3. Strowig T, Henao-Mejia J, Elinav E, Flavell R. Inflammasomes in health and disease. Nature 2012; 481: 278-286 [PMID: 22258606 DOI: 10.1038/nature10759]
4. Szabo G, Csak T. Inflammasomes in liver diseases. J Hepatol 2012; 57: 642-654 [PMID: 22634126 DOI: 10.1016/j.jhep.2012.03.035]
5. Martinon F. Detection of immune danger signals by NALP3. J Leukoc Biol 2008; 83: 507-511 [PMID: 17982111 DOI: 10.1189/jlb.0607362]
6. Pétrilli V, Dostert C, Muruve DA, Tschopp J. The inflammasome: a danger sensing complex triggering innate immunity. Curr Opin Immunol 2007; 19: 615-622 [PMID: 17977705 DOI: 10.1016/j.coi.2007.09.002]
7. Vandanmagsar B, Youm YH, Ravussin A, Galgani JE, Stadler K, Mynatt RL, Ravussin E, Stephens JM, Dixit VD. The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance. Nat Med 2011; 17: 179-188 [PMID: 21217695 DOI: 10.1038/nm.2279]
8. Stienstra R, van Diepen JA, Tack CJ, Zaki MH, van de Veerdonk FL, Perera D, Neale GA, Hooiveld GJ, Hijmans A, Vroegrijk I, van den Berg S, Romijn J, Rensen PC, Joosten LA, Netea MG, Kanneganti TD. Inflammasome is a central player in the induction of obesity and insulin resistance. Proc Natl Acad Sci USA 2011; 108: 15324-15329 [PMID: 21876127 DOI: 10.1073/pnas.1100255108]
9. Dixon LJ, Flask CA, Papouchado BG, Feldstein AE, Nagy LE. Caspase-1 as a central regulator of high fat diet-induced nonalcoholic steatohepatitis. PLoS One 2013; 8: e56100 [PMID: 23409132 DOI: 10.1371/journal.pone.0056100]
10. de Almeida IT, Cortez-Pinto H, Fidalgo G, Rodrigues D, Camilo ME. Plasma total and free fatty acids composition in human nonalcoholic steatohepatitis. Clin Nutr 2002; 21: 219-223 [PMID: 12127930 DOI: 10.1054/clnu.2001.0529]
11. Puri P, Wiest MM, Cheung O, Mirshahi F, Sargeant C, Min HK, Contos MJ, Sterling RK, Fuchs M, Zhou H, Watkins SM, Sanyal AJ. The plasma lipidomic signature of nonalcoholic steatohepatitis. Hepatology 2009; 50: 1827-1838 [PMID: 19937697 DOI: 10.1002/hep.23229]
12. Shi H, Kokoeva MV, Inouye K, Tzameli I, Yin H, Flier JS. TLR4 links innate immunity and fatty acid-induced insulin resistance. J Clin Invest 2006; 116: 3015-3025 [PMID: 17053832 DOI: 10.1172/JCI28898]
13. Wen H, Gris D, Lei Y, Jha S, Zhang L, Huang MT, Brickey WJ, Ting JP. Fatty acid-induced NLRP3-ASC inflammasome activation interferes with insulin signaling. Nat Immunol 2011; 12: 408-415 [PMID: 21478880 DOI: 10.1038/ni.2022]
14. Csak T, Ganz M, Pespisa J, Kodys K, Dolganiuc A, Szabo G. Fatty acid and endotoxin activate inflammasomes in mouse hepatocytes that release danger signals to stimulate immune cells. Hepatology 2011; 54: 133-144 [PMID: 21488066 DOI: 10.1002/hep.24341]
15. L'homme L, Esser N, Riva L, Scheen A, Paquot N, Piette J, Legrand-Poels S. Unsaturated fatty acids prevent activation of NLRP3 inflammasome in human monocytes/macrophages. J Lipid Res 2013; 54: 2998-3008 [PMID: 24006511 DOI: 10.1194/jlr. M037861]
16. Yan Y, Jiang W, Spinetti T, Tardivel A, Castillo R, Bourquin C, Guarda G, Tian Z, Tschopp J, Zhou R. Omega-3 fatty acids prevent inflammation and metabolic disorder through inhibition of NLRP3 inflammasome activation. Immunity 2013; 38: 1154-1163 [PMID: 23809162 DOI: 10.1016/j.immuni.2013.05.015]
17. Gross O, Thomas CJ, Guarda G, Tschopp J. The inflammasome: an integrated view. Immunol Rev 2011; 243: 136-151 [PMID: 21884173 DOI: 10.1111/j.1600-065X.2011.01046.x]
18. Zhou R, Tardivel A, Thorens B, Choi I, Tschopp J. Thioredoxininteracting protein links oxidative stress to inflammasome activation. Nat Immunol 2010; 11: 136-140 [PMID: 20023662 DOI: 10.1038/ni.1831]
19. Zhou R, Yazdi AS, Menu P, Tschopp J. A role for mitochondria in NLRP3 inflammasome activation. Nature 2011; 469: 221-225 [PMID: 21124315 DOI: 10.1038/nature09663]
20. Hua J, Ma X, Webb T, Potter JJ, Oelke M, Li Z. Dietary fatty acids modulate antigen presentation to hepatic NKT cells in nonalcoholic fatty liver disease. J Lipid Res 2010; 51: 1696-1703 [PMID: 20185414 DOI: 10.1194/jlr.M003004]
21. Ganz M, Csak T, Nath B, Szabo G. Lipopolysaccharide induces and activates the Nalp3 inflammasome in the liver. World J Gastroenterol 2011; 17: 4772-4778 [PMID: 22147977 DOI: 10.3748/wjg.v17.i43.4772]
22. Miura K, Yang L, van Rooijen N, Brenner DA, Ohnishi H, Seki E. Toll-like receptor 2 and palmitic acid cooperatively contribute to the development of nonalcoholic steatohepatitis through inflammasome activation in mice. Hepatology 2013; 57: 577-589 [PMID: 22987396 DOI: 10.1002/hep.26081]
23. Ma X, Hua J, Li Z. Probiotics improve high fat diet-induced hepatic steatosis and insulin resistance by increasing hepatic NKT cells. J Hepatol 2008; 49: 821-830 [PMID: 18674841 DOI: 10.1016/j.jhep.2008.05.025]
24. Schroder K, Tschopp J. The inflammasomes. Cell 2010; 140: 821-832 [PMID: 20303873 DOI: 10.1016/j.cell.2010.01.040]
25. Reynolds CM, McGillicuddy FC, Harford KA, Finucane OM, Mills KH, Roche HM. Dietary saturated fatty acids prime the NLRP3 inflammasome via TLR4 in dendritic cells-implications for diet-induced insulin resistance. Mol Nutr Food Res 2012; 56: 1212-1222 [PMID: 22700321 DOI: 10.1002/mnfr.201200058]
26. Kim S, Joe Y, Jeong SO, Zheng M, Back SH, Park SW, Ryter SW, Chung HT. Endoplasmic reticulum stress is sufficient for the induction of IL-1 production via activation of the NF-B and inflammasome pathways. Innate Immun 2014; 20: 799-815 [PMID: 24217221 DOI: 10.1177/1753425913508593]
27. Harte AL, da Silva NF, Creely SJ, McGee KC, Billyard T, Youssef-Elabd EM, Tripathi G, Ashour E, Abdalla MS, Sharada HM, Amin AI, Burt AD, Kumar S, Day CP, McTernan PG. Elevated endotoxin levels in non-alcoholic fatty liver disease. J Inflamm (Lond) 2010; 7: 15 [PMID: 20353583 DOI: 10.1186/1476-9255-7-15]
28. Kudo H, Takahara T, Yata Y, Kawai K, Zhang W, Sugiyama T. Lipopolysaccharide triggered TNF-alpha-induced hepatocyte apoptosis in a murine non-alcoholic steatohepatitis model. J Hepatol 2009; 51: 168-175 [PMID: 19446916 DOI: 10.1016/j.jhep.2009.02.032]
29. Keshavarzian A, Farhadi A, Forsyth CB, Rangan J, Jakate S, Shaikh M, Banan A, Fields JZ. Evidence that chronic alcohol exposure promotes intestinal oxidative stress, intestinal hyperpermeability and endotoxemia prior to development of alcoholic steatohepatitis in rats. J Hepatol 2009; 50: 538-547 [PMID: 19155080 DOI: 10.1016/j.jhep.2008.10.028]
30. Bauernfeind FG, Horvath G, Stutz A, Alnemri ES, MacDonald K, Speert D, Fernandes-Alnemri T, Wu J, Monks BG, Fitzgerald KA, Hornung V, Latz E. Cutting edge: NF-kappaB activating pattern recognition and cytokine receptors license NLRP3 inflammasome activation by regulating NLRP3 expression. J Immunol 2009; 183: 787-791 [PMID: 19570822 DOI: 10.4049/jimmunol.0901363]
31. Depner CM, Traber MG, Bobe G, Kensicki E, Bohren KM, Milne G, Jump DB. A metabolomic analysis of omega-3 fatty acid-mediated attenuation of western diet-induced nonalcoholic steatohepatitis in LDLR-/-mice. PLoS One 2013; 8: e83756 [PMID: 24358308 DOI: 10.1371/journal.pone.0083756]
32. Ricote M, Li AC, Willson TM, Kelly CJ, Glass CK. The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation. Nature 1998; 391: 79-82 [PMID: 9422508 DOI: 10.1038/34178]
33. Williams-Bey Y, Boularan C, Vural A, Huang NN, Hwang IY, Shan-Shi C, Kehrl JH. Omega-3 free fatty acids suppress macrophage inflammasome activation by inhibiting NF-B activation and enhancing autophagy. PLoS One 2014; 9: e97957 [PMID: 24911523 DOI: 10.1371/journal.pone.0097957]